Abstract Structure

Participating Cohorts


Chronic Fatigue following Acute EBV Infection in Adolescents (CEBA)

PI: Prof. Vegard Bruun Bratholm Wyller

Dept. of Paediatrics, Akershus University Hospital, Norway 


Dubbo Infection Outcome Study (DIOS)

PI: Prof. Andrew Lloyd

Viral immunology Systems Program, Kirby Institute, University of New South Wales, Australia


Auckland IM and Campylobacter gastroenteritis cohorts

PI: Prof. Rona Moss-Morris

Psychology and Neuroscience, King’s College London, UK
✉ rona.moss-morris@kcl.ac.uk


Bergen Giardiasis cohort, Norway

PI: Dr Knut-Arne Wensaas,

Research unit for general practice, NORCE Norwegian Research Centre, Bergen, Norway  
✉ knwe@norceresearch.no


Dutch Q fever study (IMPAQT)

PI: Prof. Jeannine Hautvast

Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands
✉  jeannine.hautvast@radboudumc.nl



Qure Study. Treatment of Q-fever fatigue syndrome with CBT vs doxycycline vs placebo

PIs: Prof. Chantal Bleeker-Rovers & Dr Stephan Keijmel 

University of Amsterdam, The Netherlands
✉ stephan.keijmel@radboudumc.nl


Askøy Campylobacter Outbreak Study (ASCOS)

PI: Prof Guri Rørtveit 

Dept. of global public health and primary care, University of Bergen, Norway. 

✉ guri.rotveit@uib.no


Patient-reported outcomes and thromboembolism after COVID-19 without

hospitalization (PROTROM)

PI: Prof Knut Stavem

Akershus University Hospital, Norway




Long term effects of COVID-19 in adolescents (LoTECA)

PI: Prof Vegard Bruun Bratholm Wyller

Dept. of Paediatrics and Adolescent Medicine, Akershus University Hospital, Norway

✉  v.b.b.wyller@medisin.uio.no


ReCOVer - internet-based Cognitive Behavioural Therapy [iCBT] for severe fatigue after COVID-19

PI: Prof Hans Knoop

Department of Medical Psychology, Amsterdam Public Health Research Institute,

Meibergdreef 9, Amsterdam, Amsterdam UMC, University of Amsterdam.

✉  hans.knoop@amsterdamumc.nl

LymeProspect study 

PI: Dr Kees van den Wijngaard

RIVM, Centre for Infectious Disease Control, Epidemiology and Surveillance, Netherlands

✉ kees.van.den.wijngaard@rivm.nl



PI: Dr Patrick Gérardin

Research Center for Health and Medical Science, CHU Réunion

✉ patrick.gerardin@chu-reunion.fr


RECoVERED study - Evolution of COVID-19 symptoms during the first 12

months after illness onset

PI: Prof Maria Prins

Public Health Service of Amsterdam and Amsterdam University Medical Centres (Location AMC)

✉ mprins@ggd.amsterdam.nl


Prevalence and determinants of persistent symptoms after infection with SARS-CoV-2. (LongCOVID-study)

PI: Dr Tessa van der Maaden

RIVM, Centre for Infectious Disease Control, Epidemiology and Surveillance, Netherlands